Lupus Erythematosus, Systemic: all 1,222 studies
Page 9 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Mobile Study to Measure and Predict Lupus Disease Activity Using Digital SignalsStatus unknownNCT04449653
- O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus ErythematosusCompletedNCT04440566Not applicable
- Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus StudyCompletedNCT04431167Not applicable
- PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLECompletedNCT04411407Not applicable
- Care Coordination Approaches to Learning Lupus Self-managementCompletedNCT04400240Not applicable
- Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeStatus unknownNCT04397237
- The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic DiseasesCompletedNCT04397107Not applicable
- Telemedicine for Follow-up of Systemic Lupus ErythematosusCompletedNCT04368299Not applicable
- The Role of Lipids in Immune Cell Function in SLE PatientsStatus unknownNCT04361734
- Individual Patient Exposure and Response in Pediatric LupusCompletedNCT04358302Not applicable
- Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus ErythematosusStatus unknownNCT04356014
- Covid-19 in Lupus PatientsCompletedNCT04355702
- Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseCompletedNCT04345159
- COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesTerminatedNCT04335747
- Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus ErythematosusCompletedNCT04335643Not applicable
- Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) PatientsCompletedNCT04305418Not applicable
- A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT04305197Phase 1/2
- Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus ErythematosusStatus unknownNCT04293510
- Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesActive, not recruitingNCT04276701Not applicable
- The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus ErythematosusStatus unknownNCT04275193Phase 2/3
- Establishing Clinical Utility of a New Diagnostic Test for Rheumatology PatientsCompletedNCT04266860Not applicable
- Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal ImpairmentStatus unknownNCT04256577
- Efficacy of High-intensity Laser in Jaccoud's Arthropathy in Systemic Lupus ErythematosusCompletedNCT04244539Not applicable
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- A Pilot Study to Explore the Role of Gut Flora in LupusWithdrawnNCT04213690
- Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem CellsCompletedNCT04184258Phase 1/2
- Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.CompletedNCT04180228
- Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus ErythematosusStatus unknownNCT04127747Phase 4
- Haematological Indices in Systemic Lupus ErythematosusStatus unknownNCT04110184
- Effect of Insoles in Patients With Systemic Lupus ErythematosusCompletedNCT04098055Not applicable
- Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) PatientsCompletedNCT04089930
- Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)CompletedNCT04082416Phase 3
- Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled TrialCompletedNCT04077684Phase 2
- A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus ErythematosusWithdrawnNCT04060888Phase 3
- Treatment of Periodontal Disease in Systemic Lupus ErythematosusStatus unknownNCT04046172Not applicable
- Premature Atherosclerosis in Systemic Lupus ErythematosusStatus unknownNCT04037293
- Application of MRI for Musculoskeletal Involvement in SLEStatus unknownNCT04035265Not applicable
- Contemplation-Based Intervention and Health Outcomes RCT in Lupus PatientsStatus unknownNCT04032496Not applicable
- Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care UnitStatus unknownNCT04022655
- Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to ClinicStatus unknownNCT04018222
- New Signaling Pathway Targeting Systemic Lupus ErythematosusStatus unknownNCT03984227
- Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus ErythematosusCompletedNCT03979976Phase 2/3
- Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)Status unknownNCT03975361Not applicable
- Effect of Curcumin on Systemic Lupus ErythematosusTerminatedNCT03953261Phase 2
- Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT03951259Phase 2
- Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy SubjectsCompletedNCT03949426Phase 1
- Systemic Lupus Erythematosus Exercise ProgramCompletedNCT03942718Not applicable
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Smartphone Mindfulness Meditation for Patients With Rheumatic DiseasesTerminatedNCT03937856Not applicable
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- A Study of LY3361237 in Participants With Systemic Lupus ErythematosusCompletedNCT03933943Phase 1
- Internet-Based Pain Coping Skills Training for Patients With LupusCompletedNCT03933839Not applicable
- BAFF and APRIL and RESPONSE TO BELIMUMAB in SLEStatus unknownNCT03919643
- Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of LupusCompletedNCT03896373
- Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)Status unknownNCT03878303Phase 1
- A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus ErythematosusWithdrawnNCT03866317Phase 2
- Anti-ficolin-3 Antibodies in Lupus NephritisCompletedNCT03842787
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompletedNCT03817424Phase 1
- Glucocorticoids Withdrawal in Early Systemic Lupus ErythematosusStatus unknownNCT03804723Not applicable
- The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' PatientsCompletedNCT03802578Not applicable
- BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)WithdrawnNCT03771885Phase 1
- Cell Surface Marker Expression in Autoimmune DiseasesCompletedNCT03757065
- Synergetic B-cell Immunomodulation in SLE - 2nd Study.CompletedNCT03747159Phase 3
- Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusStatus unknownNCT03746197Not applicable
- The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus PregnanciesStatus unknownNCT03746028
- Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic TechniquesCompletedNCT03687138
- RIvaroxaban for Stroke Patients With AntiPhospholipid SyndromeCompletedNCT03684564Phase 2
- Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?CompletedNCT03664908Not applicable
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
- Omega-3 Replacement With Krill Oil in Disease Management of SLECompletedNCT03626311Not applicable
- Autophagy in Systemic Lupus ErythematosusStatus unknownNCT03583853
- Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic SclerosisCompletedNCT03575156Not applicable
- Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical CordStatus unknownNCT03562065Phase 1/2
- A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)CompletedNCT03556007Phase 1
- An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram EffectsCompletedNCT03541564Phase 1
- Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLECompletedNCT03537638Not applicable
- Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusCompletedNCT03527472Phase 2
- Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD)CompletedNCT03504540
- CYCLONES - CYClophosphamide LOw Dose and No Extra SteroidTerminatedNCT03492255Not applicable
- CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance TomographyTerminatedNCT03488654
- Monitoring the IMmUological TOXicity of DrugsCompletedNCT03480529
- Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in RheumatologyStatus unknownNCT03459274
- Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)Status unknownNCT03446339
- Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusCompletedNCT03427151Phase 3
- FLARE Lupus Research Study Systemic Lupus ErythematosusCompletedNCT03426384Not applicable
- Exploratory Study of DHA in Systemic Lupus Erythematosus PatientsStatus unknownNCT03396393Phase 2
- Neutrophil Extracellular Traps in Systemic SclerosisCompletedNCT03374618Not applicable
- MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLETerminatedNCT03355482Phase 2
- Scrutinizing the Heterogeneity of SLE: Defining PhenotypesStatus unknownNCT03348774
- Low-dose Interleukin-2 for Treatment of Systemic Lupus ErythematosusCompletedNCT03312335Phase 2
- Accuracy, Feasibility and Acceptance of CGM LupusStatus unknownNCT03296995Not applicable
- The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262727Phase 1
- Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus ErythematosusStatus unknownNCT03260166Phase 2
- A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet FormulationCompletedNCT03254784Phase 1
- Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesCompletedNCT03248518Not applicable
- Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus ErythematosusStatus unknownNCT03219801Early Phase 1
- GADD34 and Type I IFN Response Genes in SLECompletedNCT03206359
- Clinical Performance of BioCLIA Ro60WithdrawnNCT03204448
- Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)CompletedNCT03189875
- A Phase I Study of ICP-022 in Healthy SubjectsCompletedNCT03189017Phase 1